PLK1 - Wikipedia
Polo-like Kinase 1 Licenses CENP-A Deposition at Centromeres - ScienceDirect
Autoinhibition and relief mechanism for Polo-like kinase 4 | PNAS
Understanding the Polo Kinase machine | Oncogene
Genes | Free Full-Text | The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor?
Polo-Like Kinase-1 | SpringerLink
Frontiers | Polo-Like Kinase 4's Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy
Peptidomimetics Targeting the Polo-box Domain of Polo-like Kinase 1 | Journal of Emerging Investigators
Cancers | Free Full-Text | The CINs of Polo-Like Kinase 1 in Cancer
Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy | Leukemia
Autoinhibition and relief mechanism for Polo-like kinase 4 – The Quan Lab
Full article: Polo-like kinase 1 inhibitors in mono- and combination therapies: a new strategy for treating malignancies
Polo-Like Kinase - an overview | ScienceDirect Topics
Putting a bit into the polo-box domain of polo-like kinase 1 | Journal of Analytical Science and Technology | Full Text
The family of human Polo-like kinases. Primary structure of human... | Download Scientific Diagram
Functions of Polo-Like Kinases: A Journey From Yeast To Humans | Bentham Science
Polo-like Kinase Inhibitor III | CAS 660868-91-7 | SCBT - Santa Cruz Biotechnology
Cancers | Free Full-Text | The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis
Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic Potential | Journal of Medicinal Chemistry
A unified view of spatio-temporal control of mitotic entry: Polo kinase as the key | Open Biology
Frontiers | A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas
Polo-Like Kinase - an overview | ScienceDirect Topics
Polo-like Kinase (PLK) (Inhibitors Agonists Modulators Antagonists) | MedChemExpress
